Agnikarma and marma therapy in sciatica(lower back pain)
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: G959- Disease of spinal cord, unspecified
- Registration Number
- CTRI/2020/04/024786
- Lead Sponsor
- Rishikul campus
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
known cases of sciatica
patients having classical sign and symptoms of sciatica
positive slr test
positive lasegues test
Exclusion Criteria
uncontrolled DM
T.B. of spine
malignancy of spine or other organ
history of spine fracture (trauma)
uncontrolled HTN
cardiac diseases
anaemia
pregnancy
age below 20 and above 70 years
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pain relieve by VAS <br/ ><br>by SLR test <br/ ><br>by Lasegue testTimepoint: 1 month
- Secondary Outcome Measures
Name Time Method Relief in pain <br/ ><br>improvement in SLR Test <br/ ><br>improvement in Lasegue testTimepoint: 1 month
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Agnikarma and Marma therapy in treating sciatica (G959)?
How does Shad-dharan yog complement Agnikarma and Marma therapy for spinal cord disease management?
What are the comparative efficacy outcomes of Agnikarma vs. standard-of-care treatments for sciatica?
Which biomarkers could predict response to Agnikarma and Marma therapy in lower back pain patients?
What adverse events are associated with Agnikarma and Marma therapy in Gridhrasi treatment?